Delivery Order SPE2DB22D3004-SPE2DB25FQ92C
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,317.28 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of September 10, 2025, issued on September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,895.50 to AmerisourceBergen Drug Corp for the supply of Nexium DR 20 mg capsules (30-count units). The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Nexium DR 40 mg capsules (90-count units) with a ceiling value of $1,687.56. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexium DR 40 mg capsules (90-count) valued at $9,382.42. This firm fixed price, non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item delivery under the company's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a $2,351.58 delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules. This firm fixed-price contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a direct delivery order under AmerisourceBergen's broader pharmaceutical supply agreement. The contract utilizes no set-aside designation and was awarded competitively. Performance will occur at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.56 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nexium DR 40 mg capsules (90-count unit) with a ceiling value of $5,138.14. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Nexium DR 20 mg capsules (30-count units) with a ceiling value of $1,687.86. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award of this pharmaceutical supply requirement. The contract is set to complete by September 26, 2025, with performance fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on July 31, 2025, for the supply of Nexium DR 40 mg capsules (90-count units) with a contract ceiling value of $2,852.62. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Nexium DR 40 mg capsules (90-count units) with a ceiling value of $9,251.86. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ92CDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,875.20 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Nexium DR 40 mg capsules (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 26, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen leverages this prime IDC to supply a broad range of medications, vaccines, and medical supplies to support military and veteran healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The Nexium delivery represents a routine pharmaceutical supply transaction typical of the company's extensive portfolio of delivery orders supporting federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/25/25 |